Literature DB >> 1168160

Thorotrast and the liver: a reminder.

M Selinger, R S Koff.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1168160

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

Review 1.  Nanoparticle contrast agents for X-ray imaging applications.

Authors:  Jessica C Hsu; Lenitza M Nieves; Oshra Betzer; Tamar Sadan; Peter B Noël; Rachela Popovtzer; David P Cormode
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-05-22

2.  Endothelial markers in malignant vascular tumours of the liver: superiority of QB-END/10 over von Willebrand factor and Ulex europaeus agglutinin 1.

Authors:  P P Anthony; P Ramani
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

3.  Veno-occlusive disease and peliosis of the liver after thorotrast administration.

Authors:  A Dejgaard; K Krogsgaard; M Jacobsen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

4.  Haemangioendothelioma (Kupffer cell angiosarcoma), myelofibrosis, splenic atrophy, and myeloma paraproteinaemia after parenteral thorotrast administration.

Authors:  R C Jennings; S E Priestley
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

Review 5.  Drug-induced liver disease.

Authors:  H J Zimmerman
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.